ArticleJACS Au2026
Cofactor-Free Serial Amplification of Tau Filaments from Alzheimer's Disease and Other Tauopathies Depends on the Conformational State of Tau Monomers.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From seeds to symptoms: the molecular landscape of tau seeding in Alzheimer's disease.Frontiers in neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Tau filaments are a defining characteristic of Alzheimer's disease (AD) and numerous other neurodegenerative disorders. The deposition of Tau protein into aggregates involves templated recruitment of Tau monomers onto the filament ends via their microtubule-binding repeats. This structural conversion is central to the propagation of Tau pathology, yet its molecular mechanisms are still poorly understood. Specifically, it is unclear whether cofactors are required for templated growth. To gain insights into this process, we probed the serial amplification of pathological Tau filaments from AD, Pick's disease (PiD), and progressive supranuclear palsy (PSP). These filaments are made from different compositions of three- and four-repeat (3R and 4R) Tau. We observe that AD Tau filaments recruit full-length 3R and 4R Tau in the absence of cofactors at low salt concentration but not at physiological salt concentration and that these filaments can be independently amplified over multiple generations. PiD Tau and PSP Tau filaments can be similarly amplified. The generated filaments retain the cross-seeding properties of the pathological seeds; PSP filaments recruit only 4R Tau, PiD filaments recruit only 3R Tau, and AD filaments recruit both. Regardless of the structural fidelity of the amplification process, we show that the Tau monomer ensemble serves as an entry point for templated growth and that the conformational state of this ensemble (expanded versus compact) determines whether propagation occurs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.